您目前瀏覽作者為 Rakesh Singh 的商品

資料筆數共計 11 筆,共計 2 頁 進階搜尋

12
Laurs & Bridz: Sales Targets and Antiviral Drug Launch
作者姓名:Sandeep Puri; Rakesh Singh; Jatin Batra;
商品類型:Case (Field)商品編號:W25457
出版日期:2021/11/19內容長度:9 頁

In October 2020, the managing director of Laurs & Bridz Pharmaceuticals Private Limited was considering changing the company’s sales strategy to reflect the challenges that India’s pharmaceutical industry was facing during the COVID-19 pandemic. The company was also considering launching a new antiviral drug. The COVID-19 pandemic had disrupted many routine sales practices, such as in-person meetings with customers, and had also affected drug .....more

Laurs & Bridz: Sales Targets and Antiviral Drug Launch - Teaching Note
作者姓名:Sandeep Puri; Rakesh Singh; Jatin Batra;
 商品編號:W25458
出版日期:2021/11/19內容長度:9 頁

Teaching note for product W25457.

Sarva Pharmaceuticals in Cambodia: Fight or Fold? - Teaching Note
作者姓名:Sandeep Puri; Rakesh Singh; Raj Agnihotri; Bindu Gupta;
 商品編號:8B20A060
出版日期:2020/07/08內容長度:12 頁

Teaching note for product 9B20A060.

Sarva Pharmaceuticals in Cambodia: Fight or Fold?
作者姓名:Sandeep Puri; Rakesh Singh; Raj Agnihotri; Bindu Gupta;
商品類型:Case (Field)商品編號:9B20A060
出版日期:2020/07/08內容長度:10 頁

In January 2020, Jai Prakash Chaubey, the managing director of Sarva Pharmaceuticals Private Limited (Sarva), needed to decide whether or not to accept a proposal from Gursim Pharmaceutical Limited (Gursim) to market some of Sarva’s products in Cambodia. Sarva had been performing well; however, the company’s profitability in Cambodia was minimal. Should Chaubey accept Gursim’s offer? Or should he hire a new country head who could drive the sales in .....more

Sarva Pharmaceuticals in Cambodia: Fight or Fold? - Presentation
作者姓名:Sandeep Puri; Rakesh Singh; Raj Agnihotri; Bindu Gupta;
 商品編號:5B20A060
出版日期:2020/07/08內容長度:177 頁

Presentation to accompany product 8B20A060.

Unilever: Using Horlicks’s Brand Equity to Lead- Teaching Note
作者姓名:Sanchita Krishna; Sandeep Puri; Rakesh Singh;
 商品編號:8B20A021
出版日期:2020/03/18內容長度:14 頁

Teaching note for product 9B20A021.

Unilever: Using Horlicks’s Brand Equity to Lead
作者姓名:Sanchita Krishna; Sandeep Puri; Rakesh Singh;
商品類型:Case (Pub Mat)商品編號:9B20A021
出版日期:2020/03/18內容長度:9 頁

In December 2018, Hindustan Unilever Limited announced that it would buy out GlaxoSmithKline Plc’s Consumer Healthcare Ltd. India business, which included popular brands such as Horlicks, Boost, and Viva. With Horlicks in its portfolio, Hindustan Unilever Limited expected to gain market share, draw synergies from individual strengths, and gain access to a larger consumer base. However, India’s health food drink category had registered only single-digit .....more

B9 Beverages: From Start-Up to Scale-Up
作者姓名:Sandeep Puri; Shalki Goel; Sanchita Krishna; Babak Hayati; Rakesh Singh;
商品類型:Case (Pub Mat)商品編號:9B19A008
出版日期:2019/03/07內容長度:14 頁

In May 2018, B9 Beverages Private Limited (B9 Beverages), the owner of craft beer Bira 91, reached a total of over US$100 million in funding after receiving $50 million from Sofina SA, a Belgian investment firm. This third round of funding would allow the company to meet the various objectives that the founder and chief executive officer had planned for the company’s new Bira 91. He wanted his India business to break even by 2019 and expand fivefold .....more

B9 Beverages: From Start-Up to Scale-Up - Teaching Note
作者姓名:Sandeep Puri; Shalki Goel; Sanchita Krishna; Babak Hayati; Rakesh Singh;
 商品編號:8B19A008
出版日期:2019/03/07內容長度:13 頁

Teaching note for product 9B19A008.

Ajanta Packaging: Key Account Management
作者姓名:Sandeep Puri; Rakesh Singh;
商品類型:Case (Field)商品編號:9B18A023
出版日期:2018/04/17內容長度:7 頁

In the fall of 2017, Ajanta Packaging (Ajanta) was among the fastest growing glass bottle-packaging companies in India. Although the company had a large buyer base of 1,700 customers, it still earned around 50 per cent of its business from 10 key accounts, including its biggest buyer, S.F. Foods (SF), which accounted for 15 per cent of Ajanta’s revenue. The position of privilege enjoyed by SF became a cause of concern for a director at Ajanta because .....more

12